The Pharmacy and Therapeutics (P&T) Committee provides recommendations for the Medicaid Preferred Drug List (PDL). The Committee is composed of Physicians & Pharmacists who meet at least quarterly to consider PDL implementation. These meetings are generally scheduled once per quarter on the third Thursday of the month at 7:00 A.M. in the Cannon Health Building at 288 N. 1460 W. in Salt Lake City, UT. The P&T Committee reserves the right to adjust the meeting schedule as necessary. Notices for exact meeting times and locations will be published in the Legal Notices sections of the Salt Lake Newspapers at least 24 hours in advance.
The meetings are open to the public. To receive public notice for this meeting by email please sign up on the Utah Public Notice website.
Listed below are meeting minutes, recording, agendas, criteria review documents, and reports regarding the P&T Committee. Criteria review documents prepared for the P&T Committee meetings will be kept on this website for at least 6 months. Please note that in the event that a meeting is not held, no minutes will be posted for that month.
Public Comments for the P&T Committee:
Public comment that responds to the materials presented by the Pharmacotherapy Outcomes Research Center at the Universityof Utah is most helpful. The foundation documents used for most reviews are prepared by the University of Utah, College of Pharmacy, and are posted on the P&T Committee website after the meeting. Manufacturers wishing to submit any additional materials they would like reviewed as part of the process to:
Joanne LaFleur, PharmD, MSPH
Professor and Director
Pharmacotherapy Outcomes Research Center
University of Utah College of Pharmacy
30 South 2000 East Room 4922
Salt Lake City, UT 84112
All materials must be clearly labeled that they are submitted for consideration as part of the State of Utah Medicaid Preferred Drug List Program review process. Materials must be received at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible), unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search.
Persons who wish to address the P&T Committee may contact Utah Medicaid by email, at email@example.com at least 7 calendar days prior to the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints.
The documents are provided as Portable Document Format (PDF) files. If you cannot view a file, please download the free reader from the link below.